Microemulsion foaming agent for treating psoriasis and preparation method thereof
A foaming agent and a technology for psoriasis are applied in the field of microemulsion foaming agent for the treatment of psoriasis and the preparation thereof, can solve the problems such as the inability to meet the treatment requirements, and achieve the effects of low production cost, simple preparation process and high safety
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] The present embodiment provides a preparation method of a microemulsion foam and investigates the therapeutic effect of the microemulsion foam on mice with psoriasis, including:
[0038] 1. Prepare a medicated microemulsion solution, mix chlorin e6 and isopropyl myristate in a ratio of 1:50 to obtain a medicated oil phase, mix caprylic acid capric acid macrogol glyceride and polyoxyethylene fat The acid ester is mixed in a ratio of 1:2 to obtain a mixed surfactant, the above-mentioned medicated oil phase and the mixed surfactant are mixed in a ratio of 3:5, stirred with a magnetic stirrer at a rotational speed of 500 rpm, and added dropwise to Ionized water, so that the volume ratio of medicated oil phase, mixed surfactant and deionized water is 3:5:5 to form a uniform microemulsion solution a.
[0039] 2. Put the microemulsion solution a into a container with a sieve pump head, and spray it with a spray head to obtain foam.
[0040] 3. Investigation on the treatment o...
Embodiment 2
[0051] The present embodiment provides a preparation method of a microemulsion foam and investigates the therapeutic effect of the microemulsion foam on mice with psoriasis, including:
[0052] 1. Prepare a drug-containing microemulsion solution, mix talaporfin and diethylene glycol monoethyl ether in a ratio of 1:100 to obtain a drug-containing oil phase, mix polyglycerol oleate and polyoxyethylene sorbitan fatty acid The ester is mixed in a ratio of 1:5 to obtain a mixed surfactant, the above-mentioned medicated oil phase and the mixed surfactant are mixed in a ratio of 1:6, stirred with a magnetic stirrer at a rotating speed of 1000 rpm, and deionized is added dropwise. water, so that the volume ratio of the medicated oil phase, mixed surfactant and deionized water is 1:6:8 to form a uniform microemulsion solution a.
[0053] 2. Put the microemulsion solution a into a container with a sieve pump head, and spray it with a spray head to obtain foam.
[0054] In this embodime...
Embodiment 3
[0059] The present embodiment provides a preparation method of a microemulsion foam and investigates the therapeutic effect of the microemulsion foam on mice with psoriasis, including:
[0060] 1. Prepare a medicated microemulsion solution, mix porfimer sodium and squalane at a ratio of 1:80 to obtain a medicated oil phase, and mix oleoyl polyoxyethylene glyceride and caprylic capric acid polyethylene glycol glyceride with Mixing in a ratio of 2:3 to obtain a mixed surfactant, mixing the above-mentioned medicated oil phase and the mixed surfactant in a ratio of 4:15, stirring with a magnetic stirrer at a rotating speed of 800 rpm, and adding deionized water dropwise, The volume ratio of the medicated oil phase, the mixed surfactant and the deionized water is 4:15:20 to form a uniform microemulsion solution a.
[0061] 2. Put the microemulsion solution a into a container with a sieve pump head, and spray it with a spray head to obtain foam.
[0062] In this embodiment, porfime...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


